Buchumschlag

Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer

People with urothelial carcinoma of the bladder are at risk for recurrence and progression following transurethral resection of a bladder tumour (TURBT). Mitomycin C (MMC) and Bacillus Calmette‐Guérin (BCG) are commonly used, competing forms of intravesical therapy for intermediate‐ or high‐risk no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hahne, Stefanie (VerfasserIn) , Kunath, Frank (VerfasserIn) , Coles, Bernadette (VerfasserIn) , Draeger, Desiree Louise (VerfasserIn) , Krabbe, Laura-Maria (VerfasserIn) , Dersch, Rick (VerfasserIn) , Kilian, Samuel (VerfasserIn) , Jensen, Katrin (VerfasserIn) , Dahm, Philipp (VerfasserIn) , Meerpohl, Joerg J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08 January 2020
In: The Cochrane database of systematic reviews
Year: 2020, Heft: 1
ISSN:1469-493X
DOI:10.1002/14651858.CD011935.pub2
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/14651858.CD011935.pub2
Verlag, lizenzpflichtig, Volltext: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011935.pub2/full
Volltext
Verfasserangaben:Stefanie Schmidt, Frank Kunath, Bernadette Coles, Desiree Louise Draeger, Laura-Maria Krabbe, Rick Dersch, Samuel Kilian, Katrin Jensen, Philipp Dahm, Joerg J. Meerpohl
Beschreibung
Zusammenfassung:People with urothelial carcinoma of the bladder are at risk for recurrence and progression following transurethral resection of a bladder tumour (TURBT). Mitomycin C (MMC) and Bacillus Calmette‐Guérin (BCG) are commonly used, competing forms of intravesical therapy for intermediate‐ or high‐risk non‐muscle invasive (Ta and T1) urothelial bladder cancer but their relative merits are somewhat uncertain.
Beschreibung:Gesehen am 03.04.2020
Beschreibung:Online Resource
ISSN:1469-493X
DOI:10.1002/14651858.CD011935.pub2

Ähnliche Einträge